K
Kalaris Therapeutics, Inc. (KLRS)
NGM – Real vaqt narxi. Valyuta: USD
3.94
-0.03 (-0.76%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
3.94
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:10 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
3.94
-0.03 (-0.76%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
3.94
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:10 PM EDT
This stock has a consensus price target of $19.60 based on the ratings of 7 analysts. The high is $25.00 and the low is $14.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 14 | $ 19.6 | $ 25 |
| O’zgarish | 236.54% | 371.15% | 500.96% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-06-15 | — | TD Cowen | — | Initiates Coverage On | Buy |
| 2026-05-14 | 331.47% | Wedbush | $17 | Initiates Coverage On | Outperform |
| 2026-05-13 | 534.52% | Citizens | $26 → $25 | Maintains | Market Outperform |
| 2026-04-16 | 255.33% | Morgan Stanley | $14 | Initiates Coverage On | Overweight |
| 2025-12-23 | 382.23% | Chardan Capital | $19 | Initiates Coverage On | Buy |